Article Information
History
- August 19, 2021.
Article Versions
- Version 1 (June 21, 2021 - 06:36).
- You are currently viewing Version 2 of this article (August 19, 2021 - 09:55).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Beatrice Kennedy1,
- Hugo Fitipaldi2,
- Ulf Hammar1,
- Marlena Maziarz3,
- Neli Tsereteli2,
- Nikolay Oskolkov4,
- Georgios Varotsis1,
- Camilla A Franks5,
- Lampros Spiliopoulos3,6,
- Hans-Olov Adami7,8,9,
- Jonas Björk10,11,
- Stefan Engblom12,
- Katja Fall13,14,
- Anna Grimby-Ekman15,
- Jan-Eric Litton8,
- Mats Martinell16,17,
- Anna Oudin10,18,
- Torbjörn Sjöström19,
- Toomas Timpka20,
- Carole H Sudre21,22,23,
- Mark S Graham23,
- Julien Lavigne du Cadet24,
- Andrew T. Chan25,
- Richard Davies24,
- Sajaysurya Ganesh24,
- Anna May24,
- Sébastien Ourselin23,
- Joan Capdevila Pujol24,
- Somesh Selvachandran24,
- Jonathan Wolf24,
- Tim D Spector26,
- Claire J Steves26,
- Maria F Gomez27,ꭞ,
- Paul W Franks2,ꭞ and
- Tove Fall1,ꭞ,*
- 1Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Sweden
- 2Genetic and Molecular Epidemiology Unit, Department of Clinical Sciences, Lund University Diabetes Center, Lund University, Sweden
- 3Department of Clinical Sciences, Lund University Diabetes Center, Lund University, Sweden
- 4Department of Biology, National Bioinformatics Infrastructure Sweden, Science for Life Laboratory, Lund University, Sweden
- 5Faculty of Medicine/Department of Clinical Sciences, Lund University, Sweden
- 6Skåne University Hospital, Malmö, Sweden
- 7Clinical Effectiveness Group, Institute of Health and Society, University of Oslo, Oslo, Norway
- 8Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
- 9Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA
- 10Division of Occupational and Environmental Medicine, Lund University, Sweden
- 11Clinical Studies Sweden, Forum South, Skåne University Hospital, Lund, Sweden
- 12Division of Scientific Computing, Department of Information Technology, Uppsala University, Sweden
- 13Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro, Sweden
- 14Integrative Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
- 15Biostatistics, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
- 16Department of Public Health and Caring Sciences, Uppsala University, Sweden
- 17Primary Care and Health, Region Uppsala, Sweden
- 18Department of Public Health and Clinical Medicine, Section of Sustainable health, Umeå University, Sweden
- 19Novus International Group AB, Sweden
- 20Department of Medical and Health Sciences, Linköping University, Sweden
- 21MRC Unit for Lifelong Health and Ageing at UCL, University College London, London, UK
- 22Centre for Medical Image Computing, University College London, London, UK
- 23School of Biomedical Engineering and Imaging Sciences, King’s College London, London, UK
- 24ZOE Global Ltd
- 25Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
- 26Department of Twin Research and Genetic Epidemiology, King’s College London, London, UK
- 27Diabetic Complications Unit, Department of Clinical Sciences in Malmö, Lund University Diabetes Centre, Sweden
- ↵*Corresponding authors: Tove Fall, EpiHubben, MTC-huset, 751 85 Uppsala, Sweden
, tove.fall{at}medsci.uu.se